Correlation Between Checkpoint Therapeutics and Ibio
Can any of the company-specific risk be diversified away by investing in both Checkpoint Therapeutics and Ibio at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Checkpoint Therapeutics and Ibio into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Checkpoint Therapeutics and Ibio Inc, you can compare the effects of market volatilities on Checkpoint Therapeutics and Ibio and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Checkpoint Therapeutics with a short position of Ibio. Check out your portfolio center. Please also check ongoing floating volatility patterns of Checkpoint Therapeutics and Ibio.
Diversification Opportunities for Checkpoint Therapeutics and Ibio
0.58 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Checkpoint and Ibio is 0.58. Overlapping area represents the amount of risk that can be diversified away by holding Checkpoint Therapeutics and Ibio Inc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Ibio Inc and Checkpoint Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Checkpoint Therapeutics are associated (or correlated) with Ibio. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Ibio Inc has no effect on the direction of Checkpoint Therapeutics i.e., Checkpoint Therapeutics and Ibio go up and down completely randomly.
Pair Corralation between Checkpoint Therapeutics and Ibio
Given the investment horizon of 90 days Checkpoint Therapeutics is expected to generate 0.75 times more return on investment than Ibio. However, Checkpoint Therapeutics is 1.33 times less risky than Ibio. It trades about 0.12 of its potential returns per unit of risk. Ibio Inc is currently generating about 0.02 per unit of risk. If you would invest 345.00 in Checkpoint Therapeutics on September 13, 2024 and sell it today you would earn a total of 35.00 from holding Checkpoint Therapeutics or generate 10.14% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Checkpoint Therapeutics vs. Ibio Inc
Performance |
| Timeline |
| Checkpoint Therapeutics |
| Ibio Inc |
Checkpoint Therapeutics and Ibio Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Checkpoint Therapeutics and Ibio
The main advantage of trading using opposite Checkpoint Therapeutics and Ibio positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Checkpoint Therapeutics position performs unexpectedly, Ibio can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ibio will offset losses from the drop in Ibio's long position.| Checkpoint Therapeutics vs. Mustang Bio | Checkpoint Therapeutics vs. Reviva Pharmaceuticals Holdings | Checkpoint Therapeutics vs. Fortress Biotech Pref | Checkpoint Therapeutics vs. Kodiak Sciences |
| Ibio vs. Jaguar Animal Health | Ibio vs. GeoVax Labs | Ibio vs. Ocugen Inc | Ibio vs. Tonix Pharmaceuticals Holding |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.
Other Complementary Tools
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Global Correlations Find global opportunities by holding instruments from different markets |